The resounding echoes of the abortion debate have found their way back to the hallowed halls of the U.S Supreme Court, barely 17 months after the court ended the constitutional right to the procedure, allowing states to set their own restrictions. The gripping narrative evolves as the Supreme Court turns its gaze towards an issue related to medically-induced abortions, a method rapidly gaining use. The verdict has the potential to envelop abortion rights across the nation in its wake.
Central to the dispute is Mifflin Pristone, a ubiquitous abortion drug used in conjunction with another, which has held its ground on the market for over two decades. Despite numerous attempts by abortion opponents to impose restrictions, lower court rulings have so far preserved its availability nationwide.
